questionText: To ask the Secretary of State for Health and Social Care, what progress has been made by his Department in encouraging more reclassification applications to the Medicines and Healthcare products Regulatory Agency (MHRA); whether reclassification applications will form part of the MHRA's forthcoming strategy; and what assessment he has made of the potential impact of reclassification applications on (a) the NHS, (b) patients and (c) the Exchequer.
answerText: The Government supports the reclassification of medicines where it is safe and appropriate to do so, as this can improve patient access and support selfcare while maintaining high standards of public health protection. The Medicines and Healthcare product...
heading: NHS: Drugs